Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ABL Diagnostics commercializes proprietary genotyping and molecular diagnostic assays for a broad range of infectious pathogens (HIV, SARS-CoV-2, HBV, TB, etc.) and digital solutions for clinical management, with market validation through CE-IVD marking and broad clinical adoption. They do not conduct interventional clinical trials, as they are an IVD diagnostics company rather than a therapeutic/biotech drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ABL Diagnostics.